Unknown PHASE4 INTERVENTIONAL 2-arm NCT01608698

Comparison of Body Weight Change During Contraception With Belara and Yasmin

A Comparison of Body Weight Changing and Side Effects Between Treatment With 30 mcg Ethinylestradiol/2 mg Chlormadinone Acetate (Belara®) and 30 mcg Ethinylestradiol/3 mg Drospirenone (Yasmin®): A Randomized Control Trial

Sponsor: Mahidol University

Conditions Body Weight Changes

Interventions 30 mcg ethinylestradiol/2 mg chlormadinone acetate 30 mcg ethinylestradiol/3 mg drospirenone

Updated 6 times since 2017 Last updated: Apr 7, 2015 Started: Jun 30, 2012 Primary completion: Jan 31, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01608698, this PHASE4 trial focuses on Body Weight Changes and remains ongoing. Sponsored by Mahidol University, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
May 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2017 [monthly]

Enrolling By Invitation PHASE4

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mahidol University

Data source: Mahidol University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand